Molecular spectrum of excision repair cross-complementation group 8 gene defects in Chinese patients with Cockayne syndrome type A

被引:11
|
作者
Wang, Xiaozhu [1 ,2 ]
Huang, Yu [2 ]
Yan, Ming [2 ]
Li, Jiuwei [3 ]
Ding, Changhong [3 ]
Jin, Hong [3 ]
Fang, Fang [3 ]
Yang, Yanling [4 ]
Wu, Baiyan [2 ]
Chen, Dafang [1 ]
机构
[1] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100191, Peoples R China
[2] Peking Univ, Sch Basic Med Sci, Dept Med Genet, Hlth Sci Ctr, Beijing 100191, Peoples R China
[3] Capital Med Univ, Beijing Childrens Hosp, Dept Neurol, Beijing 100045, Peoples R China
[4] Peking Univ, Dept Paediat, Hosp 1, Beijing 100034, Peoples R China
来源
SCIENTIFIC REPORTS | 2017年 / 7卷
基金
中国国家自然科学基金;
关键词
MUTATIONS; ERCC8; DIAGNOSIS; PROTEIN; CSA;
D O I
10.1038/s41598-017-14034-3
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
There are two genetics complementary groups Cockayne syndrome type A and B (CS-A and CS-B OMIM 216400, 133540), which is a rare autosomal recessive segmental progeroid syndrome. Homozygous or compound heterozygous mutations in the excision repair cross-complementation group 8 gene (ERCC8) result in CS-A, and mutations in ERCC6 result in CS-B. Homozygous ERCC6/ERCC8 mutations also result in UV-sensitive syndrome. In this study, twenty-one Han Chinese patients with CS were investigated to identify mutations in ERCC8/ERCC6, of which thirteen cases with CS-A were identified with the mutations of ERCC8. There are five types mutations of ERCC8 in our study, such as exon 4 rearrangement, c.394_398delTTACA, c.299insA, c.843 + 2T > C, and c.2T > A. An estimated frequency of exon 4 rearrangement accounts for 69.23% and c.394_398delTTACA accounts for 11.53% in our cohort. Haplotype analysis revealed that the exon 4 rearrangement and c.394_398delTTACA mutations originated from a common founder in the Chinese population respectively. With the identification of three novel ERCC8 mutations, this study expanded the molecular spectrum of known ERCC8 defects, and furthermore, suggests that the exon 4 rearrangement and c.394_398delTTACA mutations may be a common underlying cause of CS-A in the Chinese population, which is different from that in other populations.
引用
收藏
页数:9
相关论文
共 50 条
  • [11] Is excision repair cross-complementation Group1 expression a biological marker in nasopharynx carcinoma
    Aksoy, Asude
    Elkiran, Emin Tamer
    Harputluoglu, Hakan
    Dagli, Adile Ferda
    Isikdogan, Abdurrahman
    Urakci, Zuhat
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (03) : 550 - 555
  • [12] Prognostic Significance of Excision Repair Cross-Complementation Group 1 on Circulating Tumor Cells for Nasopharyngeal Carcinoma
    Liu, Ting
    Li, Yuanqing
    Song, Junmei
    Li, Bo
    Wang, Rensheng
    Huang, Tingting
    Qin, Yutao
    CANCER CONTROL, 2024, 31
  • [13] Expression of excision repair cross-complementation group 1 protein predicts poor outcome in patients with small cell lung cancer
    Lee, Hyun Woo
    Han, Jae Ho
    Kim, Jang Hee
    Lee, Myoung Hee
    Jeong, Seong Hyun
    Kang, Seok Yun
    Choi, Jin-Hyuk
    Oh, Young Taek
    Park, Kwang Joo
    Hwang, Sung Chul
    Sheen, Seung Soo
    Lim, Ho-Yeong
    LUNG CANCER, 2008, 59 (01) : 95 - 104
  • [14] High expression of excision repair cross-complementation group1 protein predicts poor outcome in patients with nasopharyngeal cancer
    Lee, Hyun Woo
    Hwang, Yoon Ho
    Han, Jae Ho
    Choi, Jin-Hyuk
    Kang, Seok Yun
    Jeong, Seong Hyun
    Ann, Mi Sun
    Oh, Young Taek
    Kim, Jang Hee
    Kim, Chul Ho
    Sheen, Seung Soo
    ORAL ONCOLOGY, 2010, 46 (03) : 209 - 213
  • [15] Characterization of functional excision repair cross-complementation group 1 variants and their association with lung cancer risk and prognosis
    Yu, Dianke
    Zhang, Xuemei
    Liu, Ju
    Yuan, Peng
    Tan, Wen
    Guo, Yongli
    Sun, Tong
    Zhao, Dan
    Yang, Ming
    Liu, Junniao
    Xu, Binghe
    Lin, Dongxin
    CLINICAL CANCER RESEARCH, 2008, 14 (09) : 2878 - 2886
  • [16] EXPRESSION OF EXCISION REPAIR CROSS-COMPLEMENTATION GROUP 1 AS PREDICTIVE MARKER FOR NASOPHARYNGEAL CANCER TREATED WITH CONCURRENT CHEMORADIOTHERAPY
    Sun, Jong-Mu
    Ahn, Myung-Ju
    Park, Min Jae
    Lee, Hut-Young
    Ahn, Yin Seok
    Lee, Seungkoo
    Kang, Gu
    Han, Joungho
    Son, Young-Ik
    Baek, Chung-Hwan
    Ahn, Yong Chan
    Park, Keunchil
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 80 (03): : 655 - 660
  • [17] Prognostic value of excision repair cross-complementation group 1 expression in gastric cancer: A meta-analysis
    Song, Peng
    Yin, Qin
    Lu, Ming
    Fu, Bo
    Wang, Baolin
    Zhao, Qinghong
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 9 (04) : 1393 - 1400
  • [18] Regulation of Excision Repair Cross-Complementation Group 1 by Snail Contributes to Cisplatin Resistance in Head and Neck Cancer
    Hsu, Dennis Shin-Shian
    Lan, Hsin-Yi
    Huang, Chi-Hung
    Tai, Shyh-Kuan
    Chang, Shyue-Yih
    Tsai, Tung-Lung
    Chang, Cheng-Chi
    Tzeng, Cheng-Hwai
    Wu, Kou-Juey
    Kao, Jung-Yie
    Yang, Muh-Hwa
    CLINICAL CANCER RESEARCH, 2010, 16 (18) : 4561 - 4571
  • [19] High excision repair cross-complementation group 1 expression is associated with favorable prognostic factors in breast cancer
    Kim, Dong Hyun
    Lee, Hyunjoo
    Kim, Dong-Hoon
    Chae, Seoung Wan
    Sohn, Jin Hee
    Kim, Kyungeun
    Do, Sung-Im
    ONCOLOGY LETTERS, 2017, 14 (04) : 4995 - 5003
  • [20] Emodin regulating excision repair cross-complementation group 1 through fibroblast growth factor receptor 2 signaling
    Gang Chen
    Hong Qiu
    Shan-Dong Ke
    Shao-Ming Hu
    Shi-Ying Yu
    Sheng-Quan Zou
    World Journal of Gastroenterology, 2013, 19 (16) : 2481 - 2491